EXOCULAR DX INC

From the company

ExOcular is developing a portfolio of blood-based multiplex tests that measure disease-specific biomarkers isolated from exosomes to help manage severe eye diseases, initially focusing on diabetic retinopathy and age-related macular degeneration. Its analysis algorithms generate a quantitative Disease Severity Score to support early diagnosis, prognosis, and treatment monitoring. Headquarters and lab are located at the University of Colorado Anschutz Medical Campus.